Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
<h4>Background</h4>Hepatorenal syndrome (HRS) is a severe and progressive functional renal failure occurring in patients with cirrhosis and ascites. Terlipressin is recognized as an effective treatment of HRS, but it is expensive and not widely available. Norepinephrine could be an effec...
Main Authors: | Antonio Paulo Nassar Junior, Alberto Queiroz Farias, Luiz Augusto Carneiro D' Albuquerque, Flair José Carrilho, Luiz Marcelo Sá Malbouisson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0107466 |
Similar Items
-
Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
by: Po Huang, et al.
Published: (2019-12-01) -
Efficacy and safety of norepinephrine combined with albumin versus terlipressin combined with albumin in treatment of type 1 hepatorenal syndrome: A Meta-analysis
by: QIN Yanxin
Published: (2019-10-01) -
Noradrenaline or terlipressin for hepatorenal syndrome?
by: Pilar Celis, et al.
Published: (2015-08-01) -
Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
by: Mohamed M G Mohamed, et al.
Published: (2021-08-01) -
Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome
by: Aneesh Basheer, et al.
Published: (2018-03-01)